ROCHE HOLDING AG

ROG
Delayed Quote. Delayed  - 10/15 11:32:01 am
360.25CHF +0.87%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees : 101 465 people.
Sales per Business
20192020
Pharmaceuticals50 714.0082.5%46 491.0079.7%
Diagnostics13 037.0021.2%13 852.0023.8%
CHF in Million
Sales per region
20192020
United States31 164.0050.7%28 630.0049.1%
Rest of Europe9 672.0015.7%9 785.0016.8%
Rest of Asia8 717.0014.2%8 627.0014.8%
Japan4 674.007.6%4 254.007.3%
Germany3 084.005%3 352.005.7%
Latin America2 858.004.6%2 393.004.1%
Africa, Australia and Oceania1 359.002.2%1 318.002.3%
Switzerland1 237.002%1 101.001.9%
Rest of North America986.001.6%883.001.5%
CHF in Million
Managers
Name Title
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Technology Officer
Christoph Franz Chairman
Urs Jaisli Chief Compliance Officer
André S. Hoffmann Vice Chairman
Paul Bulcke Non-Executive Director
Bernard J. Poussot Non-Executive Director
Richard P. Lifton Non-Executive Director
Claudia Süssmuth Dyckerhoff Director
Julie Brown Director
Shareholders
Name Equities %
Norges Bank Investment Management 19,938,101 2.84%
The Vanguard Group, Inc. 18,936,424 2.70%
Fidelity Management & Research Co. LLC 12,119,978 1.73%
BlackRock Fund Advisors 11,554,570 1.64%
UBS Asset Management Switzerland AG 11,531,596 1.64%
Roche Holding AG 9,436,750 1.34%
Credit Suisse Asset Management (Schweiz) AG 8,797,973 1.25%
Massachusetts Financial Services Co. 7,637,668 1.09%
Zürcher Kantonalbank (Investment Management) 6,902,137 0.98%
Flossbach von Storch AG 6,548,950 0.93%
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : http://www.roche.com
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ROCHE HOLDING AG27.74%339 442
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.13.20%232 621
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.2.03%193 205
ASTRAZENECA PLC20.08%187 492
NOVARTIS AG-8.03%186 330
BRISTOL-MYERS SQUIBB COMPANY-5.92%129 683
SANOFI6.53%122 086
AMGEN INC.-9.60%118 022
GLAXOSMITHKLINE PLC4.29%96 396
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-27.49%57 462
BAYER AG-0.56%54 575
JIANGSU HENGRUI MEDICINE CO., LTD.-46.12%49 566
DAIICHI SANKYO COMPANY, LIMITED-16.76%49 400
TAKEDA PHARMACEUTICAL COMPANY LIMITED-13.93%44 517
ASTELLAS PHARMA INC.25.60%32 494
Brand Portfolio
ROCHE
ROCHE
FLATIRON HEALTH
FLATIRON HEALTH
FOUNDATION MEDICINE
FOUNDATION MEDICINE
GENENTECH
GENENTECH
PROMEDIOR
PROMEDIOR
STRATOS GENOMICS
STRATOS GENOMICS
TROPHOS
TROPHOS
VIEWICS
VIEWICS
» More brands of Roche Holding AG